Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study.

Therapeutic advances in endocrinology and metabolism·2026

Same author

Exercise-Induced Irisin Antagonizes TGFBR2 to Attenuate Islet Fibrosis and Improve Glucose Homeostasis in Type 2 Diabetes.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Subgroups of Prediabetes and the Risk of Cardiometabolic Multimorbidity in Chinese Adults: A Prospective Cohort Study.

Journal of diabetes·2026

Same author

Gender-Specific Associations of Muscle Strength With Diabetic Retinopathy in Middle-Aged and Older Chinese Adults: A Cross-Sectional Study.

International journal of endocrinology·2025

Same author

Dose-response relationship between the postload-fasting gap and the risk of developing diabetes: a cohort study from multiple centers in China.

BMJ open diabetes research & care·2025

Same author

Development of a scoring system for vitality capacity assessment in older adults: a population-based study.

European geriatric medicine·2025

Search research articles

Related Experiment Video

Updated: Dec 30, 2025

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Mobile Application Interventions and Weight Loss in Type 2 Diabetes: A Meta-Analysis.

Xue Cai¹, Shanhu Qiu², Dan Luo¹

¹School of Nursing, Peking University, Beijing, China.

Obesity (Silver Spring, Md.)

|January 23, 2020

Summary

Mobile apps effectively promote weight loss in type 2 diabetes patients, significantly reducing body weight and waist circumference. These digital health interventions are recommended for managing weight in this population.

More Related Videos

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

Related Experiment Videos

Last Updated: Dec 30, 2025

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Fixation and Operational Method for Abdominal Massage in T2DM Mice

Published on: March 7, 2025

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

Area of Science:

Metabolic Health
Digital Health Interventions
Clinical Research

Background:

Type 2 diabetes management often requires weight loss for improved glycemic control and reduced cardiovascular risk.
Traditional weight loss interventions face challenges in long-term adherence and accessibility.
Mobile applications offer a scalable platform for delivering behavioral interventions.

Purpose of the Study:

To systematically evaluate the efficacy of mobile application (app) interventions in promoting weight loss among individuals with type 2 diabetes.
To quantify the impact of app-based interventions on body weight, body mass index (BMI), and waist circumference.

Main Methods:

A meta-analysis was conducted, synthesizing data from randomized controlled trials (RCTs) identified through comprehensive electronic database searches.
Studies focused on mobile app interventions targeting weight loss outcomes in type 2 diabetes patients.
A random-effects model was employed to calculate pooled mean differences and 95% confidence intervals (CIs).

Main Results:

Fourteen studies involving 2,129 patients were analyzed.
Mobile app interventions significantly reduced body weight (mean difference: -0.84 kg; 95% CI: -1.51 to -0.17 kg) and waist circumference (mean difference: -1.35 cm; 95% CI: -2.16 to -0.55 cm).
No significant reduction in BMI was observed (mean difference: -0.08 kg/m²; 95% CI: -0.41 to 0.25 kg/m²).

Conclusions:

Mobile application interventions are effective in achieving weight loss and reducing waist circumference in patients with type 2 diabetes.
The benefits were more pronounced in patients with obesity and when apps were combined with other behavioral strategies.
App functionalities and intervention duration did not significantly moderate weight loss outcomes.